Logo
Search for

Volume 19, Issue 1, Pages 55-58 (February 2010)


View previous. 14 of 17 View next.

Breast-conserving surgery in 201 very young patients (<35 years)

Oreste GentiliniaCorresponding Author Informationemail address, Edoardo Botterib, Nicole Rotmenszb, Antonio Toescaa, Helio De Oliveiraa, Claudia Sangallia, Marco Colleonic, Mattia Intraa, Viviana Galimbertia, Paolo Veronesiad, Alberto Luinia, Umberto Veronesia

Received 24 July 2009; received in revised form 7 October 2009; accepted 5 November 2009. published online 30 November 2009.

Abstract 

Introduction

Surgical treatment of breast cancer in very young patients (<35 years) is still a matter of debate, since age is a predictive factor of local recurrence after breast conservation.

Patients and Methods

We retrospectively evaluated outcome and prognostic factors of 201 consecutive patients treated with breast conservation followed by whole breast irradiation between 1997 and 2004 with special attention paid to local control. The average follow up was 72 months (range 13–133 months).

Results

The mean age was 32 years (Range 20–34). Invasive ductal carcinoma was found in 175 (87.1%) patients. Two (1%) patients had invasive lobular carcinoma. One-hundred and eighteen patients (58.7%) had tumors of 2 cm or smaller. Sentinel lymph node biopsy was performed in 105 (52.2%) patients. One-hundred and ten (54.7%) patients had node-negative disease, 68 (33.8%) patients had 1–3 positive nodes and 23 (11.4%) +4 positive nodes. Eighteen patients (9.0%) developed a local recurrence, 25 (12.5%) developed distant metastases and 23 patients (11.4%) died during follow up. The 5- and 10-year cumulative incidence of local events were 8.2% and 12,3% respectively. The univariate analysis did not identify any variables affecting local disease-free survival.

Conclusions

Breast conservation in very young patients achieves an acceptable local control rate. No prognostic factors were associated with local events.

a Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, 20141, Milano, Italy

b Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy

c Department of Medical Oncology, Unity of Clinical Research, European Institute of Oncology, Milano, Italy

d Univertsity of Milan School of Medicine, European Institute of Oncology, Milano, Italy

Corresponding Author InformationCorresponding author. Tel.: +39 0257489376; fax: +39 0257489780.

PII: S0960-9776(09)00161-1

doi:10.1016/j.breast.2009.11.001


View previous. 14 of 17 View next.